DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 208 filers reported holding DENALI THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $165,478,096 | +33.3% | 7,126,533 | +17.8% | 0.04% | +28.6% |
| Q1 2024 | $124,145,118 | +98.8% | 6,049,957 | +107.9% | 0.03% | +86.7% |
| Q4 2023 | $62,438,471 | +5.1% | 2,909,528 | +1.0% | 0.02% | -6.2% |
| Q3 2023 | $59,421,063 | -29.0% | 2,880,323 | +1.5% | 0.02% | -27.3% |
| Q2 2023 | $83,739,111 | +47.2% | 2,837,652 | +14.9% | 0.02% | +37.5% |
| Q1 2023 | $56,881,705 | -9.5% | 2,468,824 | +9.2% | 0.02% | -15.8% |
| Q4 2022 | $62,868,454 | +2272.4% | 2,260,642 | +2475.7% | 0.02% | +1800.0% |
| Q3 2022 | $2,650,000 | – | 87,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 19,462,500 | $404,042,000 | 54.41% |
| Bratton Capital Management, L.P. | 953,035 | $19,785,000 | 29.05% |
| Flagship Pioneering Inc. | 8,005,747 | $166,199,000 | 7.19% |
| Casdin Capital, LLC | 400,000 | $8,304,000,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 4,410,457 | $91,561,000 | 0.65% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 22,595 | $469,000 | 0.37% |
| MARK ASSET MANAGEMENT LP | 70,532 | $1,464,000 | 0.34% |
| Artal Group S.A. | 400,000 | $8,304,000 | 0.34% |
| PIER 88 INVESTMENT PARTNERS LLC | 27,650 | $574,000 | 0.24% |
| WASATCH ADVISORS LP | 996,147 | $20,680,000 | 0.20% |